Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12096885rdf:typepubmed:Citationlld:pubmed
pubmed-article:12096885lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:12096885lifeskim:mentionsumls-concept:C0684224lld:lifeskim
pubmed-article:12096885lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:12096885lifeskim:mentionsumls-concept:C0027912lld:lifeskim
pubmed-article:12096885lifeskim:mentionsumls-concept:C0031208lld:lifeskim
pubmed-article:12096885lifeskim:mentionsumls-concept:C0439611lld:lifeskim
pubmed-article:12096885lifeskim:mentionsumls-concept:C0332514lld:lifeskim
pubmed-article:12096885pubmed:issue4lld:pubmed
pubmed-article:12096885pubmed:dateCreated2002-7-4lld:pubmed
pubmed-article:12096885pubmed:abstractTextDevelopment of some immune-mediated disorders may depend on dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. To explore neuropsychologic mechanisms in relation to the abnormal endocrine reactivity in patients with systemic lupus erythematosus (SLE) and chronic hepatitis C (CHC) we used the corticotropin releasing hormone (CRH) test, the Minnesota Multiphasic Personality Inventory (MMPI), and the Edinburgh Inventory of Manual Preference Inventory (EIMP). Compared to controls, the adrenocorticotrophic hormone (ACTH) response to CRH was reduced in CHC, while SLE presented reduced baseline dehydroepiandrosterone sulfate levels; higher neurotic scores were found in SLE and higher behavior deviant scores in CHC. Peak ACTH levels were a significant factor for the MMPI profile variability, while the manual preference score was a significant factor for the ACTH response. Personality and manual preference contribute to neuroendocrine abnormalities. Different behavioral and neuroimmunoendocrine models emerge for these disorders.lld:pubmed
pubmed-article:12096885pubmed:languageenglld:pubmed
pubmed-article:12096885pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12096885pubmed:citationSubsetIMlld:pubmed
pubmed-article:12096885pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12096885pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12096885pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12096885pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12096885pubmed:statusMEDLINElld:pubmed
pubmed-article:12096885pubmed:monthAuglld:pubmed
pubmed-article:12096885pubmed:issn0889-1591lld:pubmed
pubmed-article:12096885pubmed:authorpubmed-author:AlvesJJlld:pubmed
pubmed-article:12096885pubmed:authorpubmed-author:do ValeSSlld:pubmed
pubmed-article:12096885pubmed:authorpubmed-author:MartinsJ...lld:pubmed
pubmed-article:12096885pubmed:authorpubmed-author:TrincaAnaAlld:pubmed
pubmed-article:12096885pubmed:authorpubmed-author:GrimaBrunoBlld:pubmed
pubmed-article:12096885pubmed:authorpubmed-author:VasconcelosTe...lld:pubmed
pubmed-article:12096885pubmed:authorpubmed-author:RisoNunoNlld:pubmed
pubmed-article:12096885pubmed:authorpubmed-author:RiscadoVazVlld:pubmed
pubmed-article:12096885pubmed:authorpubmed-author:da CostaJ...lld:pubmed
pubmed-article:12096885pubmed:copyrightInfoCopyright 2001 Elsevier Science (USA).lld:pubmed
pubmed-article:12096885pubmed:issnTypePrintlld:pubmed
pubmed-article:12096885pubmed:volume16lld:pubmed
pubmed-article:12096885pubmed:ownerNLMlld:pubmed
pubmed-article:12096885pubmed:authorsCompleteYlld:pubmed
pubmed-article:12096885pubmed:pagination383-97lld:pubmed
pubmed-article:12096885pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12096885pubmed:meshHeadingpubmed-meshheading:12096885...lld:pubmed
pubmed-article:12096885pubmed:meshHeadingpubmed-meshheading:12096885...lld:pubmed
pubmed-article:12096885pubmed:meshHeadingpubmed-meshheading:12096885...lld:pubmed
pubmed-article:12096885pubmed:meshHeadingpubmed-meshheading:12096885...lld:pubmed
pubmed-article:12096885pubmed:meshHeadingpubmed-meshheading:12096885...lld:pubmed
pubmed-article:12096885pubmed:meshHeadingpubmed-meshheading:12096885...lld:pubmed
pubmed-article:12096885pubmed:meshHeadingpubmed-meshheading:12096885...lld:pubmed
pubmed-article:12096885pubmed:meshHeadingpubmed-meshheading:12096885...lld:pubmed
pubmed-article:12096885pubmed:meshHeadingpubmed-meshheading:12096885...lld:pubmed
pubmed-article:12096885pubmed:meshHeadingpubmed-meshheading:12096885...lld:pubmed
pubmed-article:12096885pubmed:meshHeadingpubmed-meshheading:12096885...lld:pubmed
pubmed-article:12096885pubmed:meshHeadingpubmed-meshheading:12096885...lld:pubmed
pubmed-article:12096885pubmed:meshHeadingpubmed-meshheading:12096885...lld:pubmed
pubmed-article:12096885pubmed:meshHeadingpubmed-meshheading:12096885...lld:pubmed
pubmed-article:12096885pubmed:meshHeadingpubmed-meshheading:12096885...lld:pubmed
pubmed-article:12096885pubmed:meshHeadingpubmed-meshheading:12096885...lld:pubmed
pubmed-article:12096885pubmed:meshHeadingpubmed-meshheading:12096885...lld:pubmed
pubmed-article:12096885pubmed:year2002lld:pubmed
pubmed-article:12096885pubmed:articleTitlePersonality, brain asymmetry, and neuroendocrine reactivity in two immune-mediated disorders: a preliminary report.lld:pubmed
pubmed-article:12096885pubmed:affiliationEndocrine Department, Hospital de Curry Cabral, Lisbon, Portugal. rop25748@mail.telepac.ptlld:pubmed
pubmed-article:12096885pubmed:publicationTypeJournal Articlelld:pubmed